Chronic Obstructive Pulmonary Disease
People who go to a skilled nursing facility after being hospitalized for chronic obstructive pulmonary disease are about twice as likely to die within a year, according to recently released findings.
The U.S. Food and Drug Administration have approved GlaxoSmithKline's Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.
Two asthma inhalers are being phased out, the Food and Drug Administration announced at the end of May.
Even if county nursing home workers provide poor care, the county is not liable unless the inadequate care results directly from an official policy or custom, a federal judge has ruled.
The Centers for Medicare & Medicaid Services has proposed changing the way hospital readmission penalties are calculated as part of its 2014 Medicare rate update. Potential readmissions penalties for long-term care providers — such as those recently floated by the White House — would likely be based on the established CMS formula for hospitals.
A new treatment may be available for patients with chronic obstructive pulmonary disorder, following a Food and Drug Administration advisory panel making a positive recommendation.
Long-term daily doses of the antibiotic azithromycin helped prevent life-threatening flare-ups of chronic obstructive pulmonary disease, a new study finds.
Individuals on long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease have been found to face greater risk of death from other cardiovascular and respiratory diseases, according to a new study published in the American Journal of Respiratory and Critical Care Medicine.